ArsenalBio Raises $325 Million in Landmark Series C Round to Accelerate Breakthrough Cell Therapies for Solid Tumors

Arsenal Biosciences, Inc. (ArsenalBio), a pioneering force in programmable cell therapy, has announced the successful closure of an oversubscribed $325 million Series C financing round. This significant funding boost reflects a growing confidence in ArsenalBio’s innovative approach to advanced CAR T-cell therapies targeting solid tumors. The Series C round attracted a host of new investors,…

Read More

Boostly Secures $5.6 Million Seed Funding to Transform Restaurant Marketing

In a significant move poised to revolutionize restaurant marketing, Boostly has announced the successful completion of a $5.6 million seed funding round. This investment was spearheaded by Trestle Partners and includes contributions from Relish Works, Singularity Capital, and Y Combinator. The funds are set to propel Boostly’s mission of equipping restaurants with cutting-edge tools to…

Read More

RXO to Acquire Coyote Logistics from UPS, Cementing Position as a Leader in North American Transportation

In a strategic move to bolster its presence in the North American transportation sector, RXO (NYSE: RXO) has announced its definitive agreement to acquire Coyote Logistics from UPS for $1.025 billion in cash. This acquisition is set to propel RXO to the forefront as the third-largest provider of brokered transportation in the region, significantly enhancing…

Read More

Oxylus Energy Secures $4.5 Million in Seed Funding to Revolutionize Green Methanol Production

Oxylus Energy, an innovative player in the clean energy sector, has successfully closed a $4.5 million Series Seed funding round. The investment, co-led by Toyota Ventures and Azolla Ventures, with additional support from Earth Foundry and Connecticut Innovations, marks a significant milestone in the company’s mission to advance green methanol technology. Oxylus Energy is pioneering…

Read More

Reframe Launches Innovative Workspace Solution to Streamline Digital Collaboration, Secures $5 Million Seed Funding

In a significant development within the tech landscape, Reframe has officially emerged from stealth mode, announcing a successful $5 million seed funding round. The financing, led by Primary Venture Partners, with Eniac Ventures as co-lead and additional participation from Founder Collective and Operator Partners, will support the company’s ambitious mission to reshape the human-computer interface….

Read More

247Solar Raises $25M Series B to Power a Round-the-Clock Industrial Energy Revolution

247Solar, the MIT-born clean energy innovator, announced a $25 million Series B funding round aimed at scaling its always-on industrial heat and electricity solutions for commercial and industrial (C&I) customers worldwide. Existing investors have already committed $3.5 million, with additional capital under active due diligence. Founded on a vision to decarbonize the hardest-to-abate industrial energy,…

Read More

Amity Solutions Secures US$60 Million to Pioneer Generative AI in Enterprise Software

Amity Solutions (ASOL), a leading software and AI firm based in Thailand, along with its parent company Amity Corporation, has successfully closed a Series C financing round raising US$60 million. This significant funding is earmarked to propel the transformation of enterprise software products through Generative AI (GenAI), aimed at enhancing value and utility across various…

Read More
DC Connected Car CEO dennis christ

DC Connected Car Accelerates AI-Powered After-Sales Revolution with €2.1 Million Seed Funding

DC Connected Car, a pioneer in AI-driven remote vehicle diagnostics, has secured €2.1 million in seed funding. The round, led by Insurtech VC firm VENPACE, also saw participation from Borusan Ventures, Atlas Ventures, Network.VC, and existing investors APX, Bloomhaus Ventures, and Business Angels. This investment will propel DC Connected Car’s mission to transform the $500…

Read More

Rejuvenate Bio Secures $4M Funding from CIRM to Advance Breakthrough Gene Therapy for Rare Heart Condition

Rejuvenate Bio, a pioneering biotechnology firm specializing in gene therapies, announced today the reception of a $4 million grant from the California Institute for Regenerative Medicine (CIRM) to propel the development of its innovative gene therapy, RJB-0402, aimed at treating desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM). Desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM) is…

Read More

Lario Therapeutics Secures $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

Lario Therapeutics, a pioneering biopharmaceutical firm dedicated to advancing precision medicines for epileptic and neurological disorders, has been awarded a substantial $6 million USD grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is earmarked to propel Lario’s preclinical research into CaV2.3 calcium channel inhibitors, heralded as a novel approach to…

Read More